PRIMARY PEDIATRIC LYMPHEDEMA: CLINICAL PRESENTATION, COMPLICATIONS, AND PREVENTION STRATEGIES
DOI:
https://doi.org/10.11603/1811-2471.2025.v.i4.15783Keywords:
lymphatic malformations, lymphedema, lymphorrhea, children, extremities, perineum and external genitalia, compression therapyAbstract
SUMMARY. The aim – to study the clinical features of the course of primary lymphostasis in children in order to improve early diagnosis and prevent complications.
Material and Methods. A retrospective analysis of 55 medical records of children with lymphatic edema of the lower extremities was performed; isolated primary lymphedema was confirmed in 22 patients aged 5–17 years. The study was conducted at the National Children's Specialized Hospital “OHMATDYT” during 2014–2024, with a minimum follow-up period of ≥36 months. The parameters analyzed included sex, age at onset, localization, progression, complications, and treatment. Diagnosis was based on physical examination (Stemmer’s sign), ultrasound, and MRI of soft tissues. Statistical analysis was performed using IBM SPSS 24.0 software, employing Pearson’s χ² test and the Mann–Whitney U test; p≤0.05 was considered statistically significant.
Results. No statistically significant difference by sex was found (p=0.67). Lower extremity involvement was observed in 81.8 % of patients (p=0.003); bilateral involvement – in 11.1 %; and combination with perineal or external genital edema – in 16.7 %. In boys, disease onset occurred within the first months of life in 60 % of cases (p<0.0001), whereas in girls, onset during puberty was observed in 50 % of cases (p<0.0001). Stemmer’s sign demonstrated high diagnostic accuracy (sensitivity ~92 %, specificity ~57 %). The main complications included recurrent soft tissue inflammation (13.6 %), erysipelas (9.1 %), and lymphorrhea (9.1 %). One patient with an atypical course and leukopenia was found to carry a GATA2 mutation. Disease progression during puberty was noted in 18.2 % of patients. All children received conservative treatment, including daytime compression garments and manual lymphatic drainage; in 27.3 % of cases, additional night bandaging was applied, allowing stabilization of disease progression.
Conclusions. Primary lymphostasis in children predominantly affects the lower extremities, sometimes extending to the perineum and external genitalia. The disease has a slow course without significant functional impairment of the limb. The most common complications are local infectious processes. An atypical course associated with leukopenia may indicate a GATA2 mutation and requires genetic testing. Early diagnosis and timely conservative therapy are effective for preventing complications and controlling disease progression.
References
Sudduth CL, Greene AK. Primary lymphedema: update on genetic basis and management. Adv Wound Care (New Rochelle). 2022;11(7):374-81. DOI: 10.1089/wound.2020.1338. DOI: https://doi.org/10.1089/wound.2020.1338
Senger JB, Kadle RL, Skoracki RJ. Current concepts in the management of primary lymphedema. Medicina (Kaunas). 2023;59(5):894. DOI: 10.3390/medicina59050894. DOI: https://doi.org/10.3390/medicina59050894
Benzar IM, Levyts'kyy AF, Dyehtyar'ova DS, Hodik OS, Dubrovin OH. Likuvannya limfatychnykh mal'formatsiy u ditey: 10-richnyy dosvid [Treatment of lymphatic malformations in children: 10-year experience]. Pediatric Surgery (Ukraine). 2022;2(75):5-14. DOI: 10.15574/PS. 2022.75.5. Ukrainian.
Duhon BH, Phan TT, Taylor SL, Crescenzi RL, Rutkowski JM. Current mechanistic understandings of lymphedema and lipedema: tales of fluid, fat, and fibrosis. Int J Mol Sci. 2022;23(12):6621. DOI: 10.3390/ijms23126621. DOI: https://doi.org/10.3390/ijms23126621
Schook CC, Mulliken JB, Fishman SJ, Grant FD, Zurakowski D, Greene AK. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg. 2011;127:2419-31. DOI: 10.1097/PRS. 0b013e318213a218. DOI: https://doi.org/10.1097/PRS.0b013e318213a218
Vignes S, Albuisson J, Champion L, Constans J, Tauveron V, Malloizel J, Quere I, Simon L, Arrault M, Trevidic P. Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins). Orphanet J Rare Dis. 2021;16:18. DOI: 10.1186/s13023-020-01652-w. DOI: https://doi.org/10.1186/s13023-020-01652-w
Watt H, Singh-Grewal D, Wargon O, Adams S. Paediatric lymphoedema: a retrospective chart review of 86 cases. J Paediatr Child Health. 2017; 53(1):38-42. DOI: 10.1111/jpc.13305. DOI: https://doi.org/10.1111/jpc.13305
Quéré I, Nagot N, Vikkula M. Incidence of cellulitis among children with primary lymphedema. N Engl J Med. 2018;378(21):2047-48. DOI: 10.1056/NEJMc1802399. DOI: https://doi.org/10.1056/NEJMc1802399
Brouillard P, Murtomäki A, Leppänen VM, et al. Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. J Clin Invest. 2024;134(14):e173586. DOI: 10.1172/JCI173586. DOI: https://doi.org/10.1172/JCI173586
Martin-Almedina S, Mortimer PS, Ostergaard P. Development and physiological functions of the lymphatic system: insights from human genetic studies of primary lymphedema. Physiol Rev. 2021;101(4):1809-71. DOI: 10. 1152/physrev.00006.2020. DOI: https://doi.org/10.1152/physrev.00006.2020
Calvo KR, Hickstein DD. The spectrum of GATA2 deficiency syndrome. Blood. 2023;141(13):1524-1532. DOI: 10.1182/blood.2022017764. DOI: https://doi.org/10.1182/blood.2022017764
Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011; 43:929-31. DOI: https://doi.org/10.1038/ng.923
Goss JA, Greene AK. Sensitivity and specificity of the Stemmer sign for lymphedema. Plast Reconstr Surg Glob Open. 2019;7:e2295. DOI: https://doi.org/10.1097/GOX.0000000000002295
Benzar I, Rebenkov S, Levytskyi A. Newborns with Kasabach–Merritt phenomenon-associated kaposiform hemangioendothelioma: a report of 6 cases. Wiad Lek. 2020;73(8):1785-89. DOI: https://doi.org/10.36740/WLek202008136
Cinar E, Ata BN, Eyigor S. Primary lymphedema of childhood: treatment results from a tertiary center. Arch Pediatr. 2024;31(4):245-49. DOI: 10.1016/j.arcped.2024. 02.002. DOI: https://doi.org/10.1016/j.arcped.2024.02.002